Mikko Neuvonen

7.2k total citations
112 papers, 5.3k citations indexed

About

Mikko Neuvonen is a scholar working on Oncology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mikko Neuvonen has authored 112 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Oncology, 47 papers in Pharmacology and 28 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mikko Neuvonen's work include Drug Transport and Resistance Mechanisms (47 papers), Pharmacogenetics and Drug Metabolism (44 papers) and Pharmacological Effects and Toxicity Studies (27 papers). Mikko Neuvonen is often cited by papers focused on Drug Transport and Resistance Mechanisms (47 papers), Pharmacogenetics and Drug Metabolism (44 papers) and Pharmacological Effects and Toxicity Studies (27 papers). Mikko Neuvonen collaborates with scholars based in Finland, Germany and United States. Mikko Neuvonen's co-authors include Pertti J. Neuvonen, Janne T. Backman, Mikko Niemi, Jouko Laitila, Aleksi Tornio, Marja K. Pasanen, Kari T. Kivistö, Lauri Kajosaari, Klaus T. Olkkola and Carl Kyrklund and has published in prestigious journals such as SHILAP Revista de lepidopterología, Antimicrobial Agents and Chemotherapy and Journal of Hepatology.

In The Last Decade

Mikko Neuvonen

110 papers receiving 5.1k citations

Peers

Mikko Neuvonen

PHARM

ONCOL

PPCH

SURGE

PHARM

Laurent Becquemont France

Ute Hofmann Germany

Kari T. Kivistö Finland

Ichiro Ieiri Japan

In‐Jin Jang South Korea

Ute I. Schwarz Canada

Zeruesenay Desta United States

Jatinder K. Lamba United States

Christian Funck‐Brentano France

Mary F. Paine United States

Laurent Becquemont France

Mikko Neuvonen

1.8k ×0.7

PHARM

1.3k ×0.6

ONCOL

1.0k ×0.8

PPCH

894 ×0.8

SURGE

958 ×1.3

PHARM

Citations per year, relative to Mikko Neuvonen Mikko Neuvonen (= 1×) peers Laurent Becquemont

Countries citing papers authored by Mikko Neuvonen

Since Specialization

Citations

This map shows the geographic impact of Mikko Neuvonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikko Neuvonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikko Neuvonen more than expected).

Fields of papers citing papers by Mikko Neuvonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikko Neuvonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikko Neuvonen. The network helps show where Mikko Neuvonen may publish in the future.

Co-authorship network of co-authors of Mikko Neuvonen

This figure shows the co-authorship network connecting the top 25 collaborators of Mikko Neuvonen. A scholar is included among the top collaborators of Mikko Neuvonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikko Neuvonen. Mikko Neuvonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Neuvonen, Mikko, et al.. (2025). Comparative uptake of statins by hepatic organic anion transporting polypeptides. European Journal of Pharmaceutical Sciences. 209. 107073–107073. 1 indexed citations

Deng, Feng, et al.. (2025). Transport of statins by multidrug resistance-associated proteins 1 and 5. European Journal of Pharmaceutical Sciences. 209. 107070–107070. 1 indexed citations

Hukkinen, Maria, Jouko Lohi, Aino Mutka, et al.. (2025). Accumulation of altered serum bile acids predicts liver injury after portoenterostomy in biliary atresia. Journal of Hepatology. 83(2). 440–452. 4 indexed citations

Neuvonen, Mikko, et al.. (2024). Non‐targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function. Clinical and Translational Science. 17(3). e13773–e13773. 3 indexed citations

Tarkiainen, E. Katriina, Mikko Neuvonen, Maria Paile‐Hyvärinen, et al.. (2024). Genome‐Wide Association Study of Atorvastatin Pharmacokinetics: Associations With SLCO1B1, UGT1A3, and LPP. Clinical Pharmacology & Therapeutics. 115(6). 1428–1440. 7 indexed citations

Deng, Feng, et al.. (2024). Ticagrelor modestly raises plasma riboflavin concentration in humans and inhibits riboflavin transport by BCRP and MRP4. Clinical Pharmacology & Therapeutics. 116(5). 1222–1226. 4 indexed citations

Neuvonen, Mikko, et al.. (2024). Screening of 16 major drug glucuronides for time-dependent inhibition of nine drug-metabolizing CYP enzymes – detailed studies on CYP3A inhibitors. European Journal of Pharmaceutical Sciences. 198. 106735–106735. 5 indexed citations

Simonen, Piia, Heli Tolppanen, Otto Hartman, et al.. (2023). The effect of hydroxychloroquine on cholesterol metabolism in statin treated patients after myocardial infarction. SHILAP Revista de lepidopterología. 53. 26–32. 3 indexed citations

Deng, Feng, Mikko Neuvonen, Christoph Wenzel, et al.. (2021). Comparative Hepatic and Intestinal Efflux Transport of Statins. Drug Metabolism and Disposition. 49(9). 750–759. 48 indexed citations

10.

Filppula, Anne M., Feng Deng, Jenni Viinamäki, et al.. (2021). Comparative Hepatic and Intestinal Metabolism and Pharmacodynamics of Statins. Drug Metabolism and Disposition. 49(8). 658–667. 26 indexed citations

11.

Pett, Helmi, John Bradley, Joseph Okebe, et al.. (2019). CYP2D6 Polymorphisms and the Safety and Gametocytocidal Activity of Single-Dose Primaquine for Plasmodium falciparum. Antimicrobial Agents and Chemotherapy. 63(10). 9 indexed citations

12.

Lilius, Tuomas O., et al.. (2013). The mineralocorticoid receptor antagonist spironolactone enhances morphine antinociception. Scandinavian Journal of Pain. 4(4). 259–259. 1 indexed citations

13.

Liukas, Antti, Kristiina Kuusniemi, Riku Aantaa, et al.. (2010). Elimination of Intravenous Oxycodone in the Elderly. Drugs & Aging. 28(1). 41–50. 32 indexed citations

14.

Lemberg, Kim K., Tarja Heiskanen, Mikko Neuvonen, et al.. (2009). Does co-administration of paroxetine change oxycodone analgesia: An interaction study in chronic pain patients. Scandinavian Journal of Pain. 1(1). 24–33. 22 indexed citations

15.

Xiang, Xiaoqiang, Yi Han, Mikko Neuvonen, et al.. (2009). Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humans. Pharmacogenetics and Genomics. 19(6). 447–457. 49 indexed citations

16.

Kalliokoski, Annikka, Mikko Neuvonen, Pertti J. Neuvonen, & Mikko Niemi. (2008). Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics and Pharmacodynamics of Repaglinide and Nateglinide. The Journal of Clinical Pharmacology. 48(3). 311–321. 77 indexed citations

17.

Neuvonen, Mikko & Pertti J. Neuvonen. (2008). Determination of Oxycodone, Noroxycodone, Oxymorphone, and Noroxymorphone in Human Plasma by Liquid Chromatography-Electrospray-Tandem Mass Spectrometry. Therapeutic Drug Monitoring. 30(3). 333–340. 38 indexed citations

18.

Kalliokoski, Annikka, Mikko Neuvonen, Pertti J. Neuvonen, & Mikko Niemi. (2008). The effect of SLCO1B1 polymorphism on repaglinide pharmacokinetics persists over a wide dose range. British Journal of Clinical Pharmacology. 66(6). 818–825. 54 indexed citations

19.

Rautiainen, Henna, Martti Färkkilâ, Mikko Neuvonen, et al.. (2006). Pharmacokinetics and bone effects of budesonide in primary biliary cirrhosis. Alimentary Pharmacology & Therapeutics. 24(11-12). 1545–1552. 15 indexed citations

20.

Jaakkola, Tiina, Janne T. Backman, Mikko Neuvonen, & Pertti J. Neuvonen. (2005). Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone. Clinical Pharmacology & Therapeutics. 77(5). 404–414. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact